Table 2 Donor characteristics and oocyte yields in reference to contraceptive use
| Â | No contraception | Androgenic | Anti-androgenic | ||||||
|---|---|---|---|---|---|---|---|---|---|
N | Mean | 95% CI | N | Mean | 95% CI | N | Mean | 95% CI | |
Age | 46 | 25.0 | 24.0–26.1 | 13 | 23.5 | 21.4–25.6 | 12 | 24.0 | 20.3–27.7 |
Menarche | 46 | 13.2 | 12.8–13.7 | 13 | 12.8 | 12.1–13.5 | 12 | 13.2 | 12.1–14.2 |
BMI | 46 | 19.8 | 19.1–20.5 | 13 | 21.1 | 19..5–22.7 | 12 | 19.5 | 18.4–20.5 |
AMH | 36 | 4.8 | 3.8–5.9 | 12 | 3.6 | 2.4–4.9 | 11 | 4.0 | 2.4–5.5 |
FSH Dose | 46 | 2276 | 2024–2560 | 13 | 2700 | 1908–3492 | 12 | 2639 | 2392–2885 |
Oocytes | 46 | 16.6 | 14.7–18.4* | 13 | 11.3 | 8.3–14.3 | 12 | 19.0 | 12.2–25.8** |